We are live on ! Find out more
GMED icon

Globus Medical

500 hedge funds and large institutions have $9.01B invested in Globus Medical in 2024 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 169 increasing their positions, 153 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 43

110% more call options, than puts

Call options by funds: $24.5M | Put options by funds: $11.7M

16% more capital invested

Capital invested by funds: $7.74B → $9.01B (+$1.27B)

11% more funds holding

Funds holding: 449500 (+51)

10% more repeat investments, than reductions

Existing positions increased: 169 | Existing positions reduced: 153

6% more funds holding in top 10

Funds holding in top 10: 1819 (+1)

0.06% more ownership

Funds ownership: 95.72%95.78% (+0.06%)

Holders
500
Holders Change
+51
Holders Change %
+11.36%
% of All Funds
6.59%
Holding in Top 10
19
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.56%
% of All Funds
0.25%
New
104
Increased
169
Reduced
153
Closed
43
Calls
$24.5M
Puts
$11.7M
Net Calls
+$12.8M
Net Calls Change
+$2.68M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
226
Tealwood Asset Management
Minnesota
$1.58M +$3.79K +48 +0.3%
OSAM
227
O'Shaughnessy Asset Management
Connecticut
$1.56M +$1.1M +14,000 +290%
LCG
228
Lisanti Capital Growth
New York
$1.52M -$519K -6,575 -26%
VI
229
Vestcor Inc
New Brunswick, Canada
$1.33M +$1.13M +14,373 +840%
Prudential Financial
230
Prudential Financial
New Jersey
$1.32M +$287K +3,637 +30%
QEI
231
QSV Equity Investors
Illinois
$1.3M
Janney Montgomery Scott
232
Janney Montgomery Scott
Pennsylvania
$1.28M -$273K -3,464 -18%
AQR Capital Management
233
AQR Capital Management
Connecticut
$1.28M +$38.6K +490 +3%
AFAS
234
Acorn Financial Advisory Services
Virginia
$1.24M -$58.8K -745 -5%
SF
235
Synovus Financial
Georgia
$1.2M +$18.4K +233 +2%
WSFS
236
Wilmington Savings Fund Society
Delaware
$1.2M
CS
237
Cannell & Spears
New York
$1.16M -$842K -10,682 -43%
LWM
238
LongView Wealth Management
Georgia
$1.16M
HIP
239
HUB Investment Partners
Texas
$1.16M +$1.1M +13,987 New
XWM
240
Xcel Wealth Management
Florida
$1.14M -$1.58K -20 -0.1%
Mariner
241
Mariner
Kansas
$1.14M +$106K +1,342 +11%
MWM
242
Moran Wealth Management
Florida
$1.13M -$5.13K -65 -0.5%
VOYA Investment Management
243
VOYA Investment Management
Georgia
$1.12M -$76.3K -968 -7%
VPIM
244
Vanguard Personalized Indexing Management
California
$1.11M +$107K +1,359 +11%
BNP Paribas Financial Markets
245
BNP Paribas Financial Markets
France
$1.1M -$2.38M -30,187 -69%
RLIM
246
Red Lighthouse Investment Management
New York
$1.1M
SOADOR
247
State of Alaska Department of Revenue
Alaska
$1.07M -$12.2K -155 -1%
X
248
Xponance
Pennsylvania
$1.07M +$60.5K +767 +6%
DT
249
Diversified Trust
Tennessee
$1.06M -$468K -5,935 -32%
SA
250
Sanctuary Advisors
Indiana
$1.05M -$53.3K -676 -6%

GMED Hedge Fund Activity: Q4 2024 in Review

500 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2024, worth a combined $9.01B — up 16% from $7.74B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new GMED positions and 43 closed out — a net gain of 61 holders — while 169 added to existing stakes and 153 trimmed.

The largest buyer was Millennium Management, adding an estimated $82.5M. The largest seller was Magnetar Financial, cutting an estimated $95.8M.

  • 500 institutional investors held Globus Medical (GMED) as of Q4 2024, up from 449 in Q3 2024.
  • Funds reported $9.01B of Globus Medical stock for Q4 2024, up 16% quarter-over-quarter.
  • 104 funds opened new Globus Medical positions in Q4 2024 and 43 closed out, a net change of +61 holders.
  • The largest Globus Medical buyer in Q4 2024 was Millennium Management, an estimated $82.5M added.
  • The largest Globus Medical seller in Q4 2024 was Magnetar Financial, an estimated $95.8M sold.

Based on aggregated 13F filings for Q4 2024.